查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1208615

2023-2030 年全球視力保健設備市場

Global Vision Care Devices Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

視力保健設備的全球市場規模預計將在 2022 年達到 124 億美元，到 2030 年達到 247.8 億美元，預測期內（2023 年至 2030 年）的複合年增長率為 12.7%。預計還會增長。

視力保健設備是用於增強或維持視力的醫療設備。 它們可以通過手術永久植入眼眶或臨時使用。 這些視力保健設備可能會或可能不會被開具處方，並且可以長期使用。

市場動態

推動全球視力保健設備市場發展的主要因素是青光眼、年齡相關性黃斑變性 (AMD)、白內障等眼病發病率的增加、技術進步以及視力保健設備的新產品發布。需求增加

提高認識的努力和新技術先進視力保健設備的興起預計將推動市場的增長。

隨著技術的不斷進步、老年人口的增加、研發投資的激增、青光眼、白內障和 AMD 等眼病患病率的增加以及新興市場醫療基礎設施的改善，視力保健設備市場正在採用最新技術。通過新產品的改進。

視力保健設備用於給藥和美容目的。 這些設備的採用正在增加，政府的努力和資金也在增加。 這些資金將用於生產人工晶狀體、眼科激光和青光眼治療設備等視力保健設備產品。 隨著眼科疾病的增加，這些應用的市場正在全球範圍內擴大。 此外，預計主要製造商提供的技術先進的產品也將在市場增長中發揮重要作用。

與這些視力保健設備相關的各種新產品發布、研究和提高認識活動正在促進市場的增長。 例如，2022 年 8 月，植入式鏡片和輸送系統的設計者和供應商 STAAR Surgical Company 宣布了其最新的植入式鏡片 EVO Visian，這是一種經 FDA 批准的視力矯正鏡片，用於矯正散光和近視。我們宣布推出一款與演員兼歌手喬喬納斯 (Joe Jonas) 建立新的合作夥伴關係，以提高人們對 Kata Colla Mellens 的認識。

與視力保健設備批准相關的產品召回和嚴格法規預計會阻礙市場增長。

關於批准用於視力保健的多種設備的嚴格規章制度是阻礙視力保健設備市場增長的主要因素。 由於必須滿足的各種要求，這些植入物的總成本增加了。 由於產品中所含器官的脆弱性，高成本和風險會阻礙生長。

市場召回也是製約市場增長的主要因素。 由於洩漏和並發症，已經有幾次召回。 例如，2022 年 10 月，羅氏公司因製造相關問題召回了其植入物 Susvimo。 Susvimo 是一種經批准的植入物，可將雷珠單抗輸送至濕性年齡相關性黃斑變性患者的眼睛。 輸送裝置的隔膜或密封件存在製造問題，無法防止藥物洩漏。

COVID-19 影響分析

疫情對全球金融預期、運營和危機應對策略產生了負面影響。 COVID-19 的爆發嚴重影響了醫療保健行業。 由於 COVID，視力保健設備市場遭受了巨大損失。 主要製造商已經啟動了各種研究和臨床試驗。 世界各地正在開展各種舉措、產品發布、合作和合併，以促進市場的增長。 例如，2020 年 7 月，植入式鏡片和輸送系統的設計者和供應商 STAAR Surgical Company 獲得了 EVO Viva/EVO Visian ICL 的 CE 標誌，這是一種用於矯正老花眼的新穎的植入式領型鏡片。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 提高人們對視力保健設備的認識
      • 不斷進步的技術進步
    • 約束因素
      • 與視力保健設備相關的產品召回
    • 商機
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 定價分析

第 6 章 COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按產品類型

  • 人工晶狀體
    • 單焦點人工晶狀體
    • 多焦點人工晶狀體
    • 可調節人工晶狀體
    • 復曲面人工晶狀體
  • 眼鏡
  • 隱形眼鏡
    • 一次性隱形眼鏡
    • 特殊隱形眼鏡
    • 透氣性隱形眼鏡
  • 青光眼引流裝置
  • 眼科激光
  • 商業眼保健品
  • 其他

第 8 章按類型

  • 處方藥
  • 非處方藥（非處方藥）

第9章應用

  • 眼科手術
    • 青光眼
    • 年齡相關性黃斑變性
    • 白內障手術後
    • 眼科手術後
    • 視網膜疾病
  • 診斷
  • 眼部護理
  • 其他

第 10 章最終用戶

  • 醫院
  • 門診手術中心
  • 眼科診所
  • 其他

第11章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第12章競爭格局

  • 主要發展和戰略
  • 公司股票分析
  • 產品基準
  • 值得關注的主要公司名單

第13章公司簡介

  • 諾華公司
    • 公司概況
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • CooperVision
  • Johnson & Johnson Services, Inc.
  • Alcon
  • Bausch & Lomb Incorporated.
  • Carl Zeiss
  • Ophtec BV
  • MORCHER GmbH
  • Safilo Group S.p.A
  • EssilorLuxottica

第14章 DataM

簡介目錄
Product Code: DMMD96

Market Overview

The global vision care devices market size was valued at US$ 12.4 billion in 2022 and is estimated to reach US$ 24.78 billion by 2030, growing at a CAGR of 12.7% during the forecast period (2023-2030).

Vision care devices are medical device that is used for enhancing and maintaining vision. These can be surgically embedded inside the socket of the eye permanently or can be used temporarily. These vision care devices can be prescribed or non-prescribed and can be used for an extended period of time.

Market Dynamics

The major factors driving the global vision care devices market are the rising demand for vision care devices owing to increasing incidences of ophthalmic disorders such as glaucoma, age-related macular degeneration (AMD) and cataract, technological advancements and novel product launches.

The increasing awareness initiatives and rising novel technologically advanced vision care devices are expected to drive the market's growth.

The vision care devices market is driven by rising advancements in technology, an increase in the geriatric population, a surge in research and development investments, an increasing number of ophthalmic disorders such as glaucoma, cataract, AMD and improvements in novel products using the latest technology along with improvements in medical infrastructure in emerging markets.

The vision care devices are used for delivering drugs and aesthetic purposes. The adoption of these devices is increasing, leading to rising government initiatives and funds. These funds will help produce vision care devices products such as intraocular lenses, ophthalmic laser or glaucoma drainage devices. The market for these applications is increasing worldwide due to the enhanced number of these ophthalmic disorders. Moreover, the availability of technologically advanced products by key players is also expected to play a vital role in the market's growth.

Various novel product launches, research studies, and rising awareness initiatives related to these vision care devices contribute to the market's growth. For instance, in August 2022, STAAR Surgical Company, a designer and provider of implantable lenses and delivery systems, announced its new partnership with Joe Jonas, an actor and singer, to create awareness of its latest implantable Collamer lenses, EVO Visian, an FDA-approved lens for vision correction developed for astigmatism and myopia correction.

Product recalls and stringent regulations associated with the approval of vision care devices are expected to hamper the market's growth.

Strict rules and regulations for the approval of several devices utilized for vision care is the major factor hindering the growth of the vision care devices market. Various requirements must be fulfilled, leading to an increase in the overall cost of these implants. The high cost and risks involved due to the sensitivity of the organ in the product are likely to hinder the growth.

Market recalls are also a leading factor restraining the growth of the market. Several recalls are taking place due to leakage or complications. For instance, in October 2022, Roche recalled its implant Susvimo due to a manufacturing-related issue. Susvimo is an approved implant that delivers ranibizumab into the eye of people with wet age-related macular degeneration. The septum or seal of the delivery device has some manufacturing issues and cannot keep the medicine from leaking out.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The Vision Care Devices market has experienced huge losses due to COVID. Key manufacturers have started various research and clinical trials. Various initiatives, product launches, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in July 2020, STAAR Surgical Company, a designer and provider of implantable lenses and delivery systems, announced its novel, innovative implantable Collamer lens, EVO Viva/ EVO Visian ICL, for presbyopia correction, received CE Mark.

Segment Analysis

The Intraocular lenses segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The intraocular lenses segment is the highest market holder in the global vision care devices market. The global vision care devices market is segmented based on product type as intraocular lenses, eye-glasses, contact lenses, glaucoma drainage devices, ophthalmic lasers, over-the-counter eye care/ supplements and others. The intraocular lenses segment is the largest market shareholder due to its inherent advantages over other implants or devices, increasing technological advancements and novel product launches.

Intraocular lenses are artificial lenses implanted into the eye for myopia or cataract treatment purposes. It replaces the natural lens of the eye removed during the surgery and restores distant or near vision. These lenses are of various types: accommodating, mono-focal, multifocal, and toric. One of the leading causes of blindness is cataracts which can be treated with the help of these implants through surgery.

The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drive the market's growth. For instance, in September 2022, Johnson and Johnson Vision, part of Johnson and Johnson Medtech and an eye health company, introduced their novel intraocular lens powered by InteliLight technology and TECNIS symphony OptiBlue intraocular lens for correcting presbyopia. This lens with depth of focus joins the hybrid lens, TECNIS synergy intraocular lens, for spectacle independence in the InteliLight portfolio. This corrects presbyopia in more patients. These deliver low-light performance and superior contrast in this intraocular lens category.

Geographical Analysis

North America holds the largest market share in the global vision care devices market.

North America dominates the global vision care devices market primarily due to its large population, excellent medical infrastructure, and high-income levels. The market is expected to grow at a relatively moderate pace during the forecast period due to healthcare expenditure in the US. The market's significant size is attributed to the high medical expenditure.

Increasing expenditure on healthcare and raising awareness among people is also contributing to the market's growth in this region. Advancement of vision care devices applications in several ophthalmic conditions, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the vision care devices market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in Aug 2020, Johnson & Johnson Vision, a company focusing on eye health, announced that its TECNIS Eyhance and TECNIS synergy intraocular lenses for cataract treatment got approved by Health Canada and will be available in the Canadian market.

Competitive Landscape

The vision care devices market is highly competitive with local and global companies' presence. Novartis Inc., Cooper Vision, Johnson & Johnson Services, Inc., STAAR Surgical, Bausch & Lomb Incorporated., Carl Zeiss, Ophtec BV, MORCHER GmbH, Safilo Group S.p.A, EssilorLuxottica and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in July 2022, Bausch + Lomb Corporation, an eye health company and Sanoculis, an ophthalmic device company, announced their strategic agreements developed to focus on glaucoma's unmet needs.

Novartis AG

Overview: Novartis is engaged in discovering, developing, manufacturing, and selling a wide range of pharmaceutical and generic medicines. The company has two operating divisions globally: Innovative medicines and Sandoz for biosimilars and generic pharmaceuticals.

Product Portfolio:

Clareon intraocular lens: This has an advanced, disposable and pre-loaded delivery system optic Type. It can be implanted with a delivery system that is unique and automated.

Key Development: In June 2022, Novartis announced its acquisition of Kedalion Therapeutics along with its innovative AcuStream technology, a device that can provide accurate delivery with precise dosing of ophthalmic medications. This acquisition will expand the ophthalmic portfolio of Novartis.

The global vision care devices market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing awareness initiatives for these vision care devices
      • 4.1.1.2. Rising technological advancements
    • 4.1.2. Restraints:
      • 4.1.2.1. Product recalls associated with vision care devices
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Intraocular Lenses *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 7.2.3. Monofocal IOLs
    • 7.2.4. MultifocalIOLs
    • 7.2.5. Accommodating IOLs
    • 7.2.6. Toric IOLs
  • 7.3. Eye Glasses
  • 7.4. Contact Lenses
    • 7.4.1. Disposable Contact Lenses
    • 7.4.2. Specialty Contact Lenses
    • 7.4.3. Gas Permeable Contact Lenses
  • 7.5. Glaucoma Drainage Devices
  • 7.6. Ophthalmic Lasers
  • 7.7. Over-the-counter Eye Care/ Supplements
  • 7.8. Others

8. By Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.1.2. Market Attractiveness Index, By Type
  • 8.2. Prescription *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Non-Prescription (Over-the-counter)

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Optical Surgeries *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 9.1.1. Glaucoma
    • 9.1.2. Age-related Macular Degeneration
    • 9.1.3. Post-Cataract Surgery
    • 9.1.4. Post Ocular Surgery
    • 9.1.5. Retinal Conditions
  • 9.2. Diagnosis
  • 9.3. Eye Care
  • 9.4. Others

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Ambulatory Surgical Centers
  • 10.4. Eye Specialty Clinics
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Products Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. Novartis AG *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. CooperVision
  • 13.3. Johnson & Johnson Services, Inc.
  • 13.4. Alcon
  • 13.5. Bausch & Lomb Incorporated.
  • 13.6. Carl Zeiss
  • 13.7. Ophtec BV
  • 13.8. MORCHER GmbH
  • 13.9. Safilo Group S.p.A
  • 13.10. EssilorLuxottica

LIST NOT EXHAUSTIVE

14. Global Vision Care Devices Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Application
  • 14.3. Contact Us